Evaluation of Graft Maturation by MRI in Anterior Cruciate Ligament Reconstruction With and Without Concomitant Anterolateral Ligament Reconstruction
Orthopaedic Journal of Sports Medicine · 2024-01 · 12 (1)
DOI: 10.1177/23259671231223976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthopaedic Journal of Sports Medicine, online erschienen am 31.01.2024. Verfasst von W P Yau und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Traumatology, Queen Mary Hospital, Hong Kong Special Administrative Region, The People's Republic of China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Single-bundle anterior cruciate ligament reconstruction (SB-ACLR) with concomitant anterolateral ligament reconstruction (ALLR) has been associated with better clinical results when compared with isolated SB-ACLR. However, it is not known whether the improved outcomes are the result of the influence of concomitant ALLR on ACL graft healing. Purpose/Hypothesis: The purpose of this study was to determine whether concomitant ALLR is associated with improved graft ligamentization after SB-ACLR. It was hypothesized that ALLR would not affect graft healing. Study Design: Cohort study; Level of evidence, 3.
Methods
A 1 to 1 matching study was conducted on a consecutive series of 732 patients who underwent ACLR using a hamstring tendon autograft between 2007 and 2019. Patients were excluded if they had skeletal immaturity, inflammatory joint disease, multiple ligament reconstruction (other than ALLR), or a graft rupture. Patients with concomitant SB-ACLR and ALLR (SB-ACLR/ALLR) and isolated SB-ACLR were matched 1 to 1 based on age, sex, examination under anesthesia (EUA) grade 3 pivot shift, EUA grade 3 anterior drawer test, presence of graft impingement, sagittal graft angle, skeletal maturity, lack of generalized ligamentous laxity, and multiple ligamentous injury. A total of 40 matched pairs underwent postoperative magnetic resonance imaging (MRI) within the second year after surgery to assess graft ligamentization, which was measured by the signal-to-noise quotient (SNQ) of the ACL graft.
Results
The mean follow-up period was 41 months, with a 2-year follow-up rate of 80% in the SB-ACLR/ALLR group and 98% in the isolated SB-ACLR group. The mean duration between the index operation and MRI was 16.4 ± 3.4 months. No significant difference was observed in the SNQ of the ACL graft between the SB-ACLR/ALLR and SB-ACLR groups (6.9 ± 4.6 vs 5.2 ± 4.8, respectively; P = .066).
Conclusion
Study findings indicated that a concomitant ALLR at the time of hamstring tendon autograft ACLR did not affect graft healing as assessed by the SNQ of the ACL graft.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics and Traumatology, Queen Mary Hospital, Hong Kong Special Administrative Region, The People's Republic of China.
- Department of Orthopaedics and Traumatology, The Duchess of Kent Children's Hospital at Sandy Bay, Hong Kong Special Administrative Region, The People's Republic of China.
Zitieren
APA
Yau, W. P., & Lin, W. (2024). Evaluation of Graft Maturation by MRI in Anterior Cruciate Ligament Reconstruction With and Without Concomitant Anterolateral Ligament Reconstruction. Orthopaedic Journal of Sports Medicine, 12(1). https://doi.org/10.1177/23259671231223976
Vancouver
Yau WP, Lin W. Evaluation of Graft Maturation by MRI in Anterior Cruciate Ligament Reconstruction With and Without Concomitant Anterolateral Ligament Reconstruction. Orthopaedic Journal of Sports Medicine. 2024;12(1). doi:10.1177/23259671231223976
BibTeX
@article{Yau2024,
author = {Yau, W P and Lin, Wei},
title = {Evaluation of Graft Maturation by MRI in Anterior Cruciate Ligament Reconstruction With and Without Concomitant Anterolateral Ligament Reconstruction},
journal = {Orthopaedic Journal of Sports Medicine},
year = {2024},
volume = {12},
number = {1},
doi = {10.1177/23259671231223976}
}
EUVIMED